Pacira | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
Astellas Pharma JPY 225.3B 25.77B 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
J&J USD 6.45B 975M 2024-12
Ligand Pharmaceuticals USD 25.6M 1.13M 2024-12
Novo Nordisk 16.59B 501M 2024-09
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12
Zoetis USD 625M 60M 2024-12



Pacira Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.